New drug ABS-201 aims to tackle hair loss in men and women
NCT ID NCT07317544
First seen Jan 09, 2026 · Last updated May 13, 2026 · Updated 15 times
Summary
This early-stage trial tests a new medication called ABS-201 to see if it is safe and tolerable for treating hair loss. It starts with healthy volunteers and then includes people with androgenetic alopecia (common baldness). Participants receive either ABS-201 or a placebo and are monitored for about a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA (AGA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Momentum Darlinghurst
RECRUITINGSydney, New South Wales, 2010, Australia
Contact
-
Nucleus Network
RECRUITINGMelbourne, Victoria, 3004, Australia
Contact
-
Nucleus Network Brisbane
RECRUITINGBrisbane, Queensland, 4006, Australia
Contact Phone: •••-•••-••••
Contact
-
Sinclair Dermatology
NOT_YET_RECRUITINGMelbourne, Victoria, 3002, Australia
Contact
Conditions
Explore the condition pages connected to this study.